Page last updated: 2024-10-28

hydroxychloroquine and Cholelithiasis

hydroxychloroquine has been researched along with Cholelithiasis in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Cholelithiasis: Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmidt, H1
Snitker, G1
Thomsen, K1
Lintrup, J1

Other Studies

1 other study available for hydroxychloroquine and Cholelithiasis

ArticleYear
Erythropoietic protoporphyria. A clinical study based on 29 cases in 14 families.
    Archives of dermatology, 1974, Volume: 110, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Biopsy; Child; Child, Preschool; Cholelithiasis; Erythrocytes;

1974